Study provides more precise estimates of cancer risks associated with low level radiation

October 21, 2015

More precise estimates of cancer risks associated with prolonged, low level exposure to ionising radiation among nuclear industry workers are published by The BMJ today.

The results suggest a linear increase in the relative rate of with increasing and strengthen the scientific basis for current radiation protection standards.

Ionising radiation is an established cause of cancer, but information on has come mainly from studies of people exposed to acute, high doses of ionising radiation, such as Japanese atomic bomb survivors. Research into associations between to moderate or low and risk of cancer began in the 1950s but estimates remain uncertain.

So an international team of researchers set out to investigate whether exposure to prolonged low doses of ionising radiation are associated with an increased risk of cancer.

The study involved 308,297 nuclear industry workers from France, the United Kingdom, and the United States. The workers, most of whom were men, were monitored for external radiation exposure, and were followed-up for an average of 27 years.

Risk estimates were then calculated for deaths from all cancers excluding leukemia. Factors such as age, duration of employment, and socioeconomic status were taken into account.

The estimated rate of mortality from all cancers excluding leukaemia increased with cumulative dose by 48% per gray (Gy). Similar associations were found within each country. Based on these estimates, the researchers suggest that about 209 of the 19,064 observed deaths due to cancer other than leukaemia were excess deaths associated with external radiation exposure.

The risk per unit dose was similar to estimates derived from studies of Japanese atomic bomb survivors, note the researchers, contrary to the belief that high dose rate exposures are more dangerous than low dose rate exposures.

This is an observational study in which bias cannot be ruled out, they say. For example, they cannot rule out the possibility that smoking and occupational asbestos exposure may have influenced the results.

"This study provides evidence of a linear increase in the excess relative rate of cancer mortality with increasing exposure to ionising radiation at the low dose rates typically encountered in the nuclear industries in France, the UK, and the USA," they write. The findings can also help strengthen the foundation for radiation protection standards, they conclude.

This study "adds to a growing body of evidence suggesting associations between exposure to moderate or low dose radiation and risk of cancer," writes Mark Little from the US National Cancer Institute, in an accompanying editorial.

But should we conclude, as this study does, that exposures at lower dose rates are just as risky as those at higher dose rates, he asks?

He suggests this conclusion may be unwarranted, pointing to several uncertainties, in particular the effect of the lower (but biologically more risky) energy of radiation received by these workers than in groups exposed at high dose rates such as the Japanese survivors. He also highlights a few weaknesses, including the lack of information on smoking and occupational exposure to asbestos, which "could conceivably confound the association between radiation dose and ."

He argues that the excess solid cancer risks associated with in this cohort are modest. "For the average worker, the lifetime risk of cancer death is likely to be increased by about 0.1% from a baseline risk of cancer death of about 25%." However, he adds, "it is equally clear that the excess risks are unlikely to be zero."

Explore further: Does radiation from X-rays and CT scans really cause cancer?

More information: Risk of cancer from occupational exposure to ionising radiation: retrospective cohort study of workers in France, the United Kingdom, and the United States (INWORKS) - www.bmj.com/cgi/doi/10.1136/bmj.h5359

Editorial: Ionising radiation in the workplace - www.bmj.com/cgi/doi/10.1136/bmj.h5405

Related Stories

Does radiation from X-rays and CT scans really cause cancer?

June 30, 2015
In recent years, there has been widespread media coverage of studies purporting to show that radiation from X-rays, CT scans and other medical imaging causes cancer.

Increased radiation offers no survival benefit for patients with low-risk prostate cancer

July 16, 2015
Increased radiation dose is associated with higher survival rates in men with medium- and high-risk prostate cancer, but not men with low-risk prostate cancer, according to a new study from Penn Medicine published this week ...

Are CT scans safe?

October 6, 2015
With questions lingering about the safety of medical imaging and the radiation that is used in some of those tests, Mayo Clinic radiation safety expert Cynthia McCollough, Ph.D., wrote a paper that provides clear answers ...

Study of Atomic-Bomb Survivors: Even lower levels of ionizing radiation exposure may lead to soft tissue cancers

February 11, 2013
In one of the largest and longest follow-up studies ever conducted to assess the effects of ionizing radiation upon the development of soft tissue sarcomas in humans, the investigators found that much lower levels than previously ...

Lifetime cancer risk from heart imaging tests is low for most children

June 9, 2014
Radiation from standard X-rays is relatively low and doesn't significantly raise lifetime cancer risks for most young children, according to research in the American Heart Association journal Circulation.

Recommended for you

Lung cancer triggers pulmonary hypertension

November 17, 2017
Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart ...

Researchers discover an Achilles heel in a lethal leukemia

November 16, 2017
Researchers have discovered how a linkage between two proteins in acute myeloid leukemia enables cancer cells to resist chemotherapy and showed that disrupting the linkage could render the cells vulnerable to treatment. St. ...

Computer program finds new uses for old drugs

November 16, 2017
Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine have developed a computer program to find new indications for old drugs. The computer program, called DrugPredict, ...

Pharmacoscopy improves therapy for relapsed blood cancer in a first clinical trial

November 16, 2017
Researchers at CeMM and the Medical University of Vienna presented a preliminary report in The Lancet Hematology on the clinical impact of an integrated ex vivo approach called pharmacoscopy. The procedures measure single-cell ...

Wider sampling of tumor tissues may guide drug choice, improve outcomes

November 15, 2017
A new study focused on describing genetic variations within a primary tumor, differences between the primary and a metastatic branch of that tumor, and additional diversity found in tumor DNA in the blood stream could help ...

A new strategy for prevention of liver cancer development

November 14, 2017
Primary liver cancer is now the second leading cause of cancer-related death worldwide, and its incidences and mortality are increasing rapidly in the United Stated. In late stages of the malignancy, there are no effective ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.